An Investigator Initiated Eight Week Two Center Open-Label Pilot Study of the Tolerability and Safety of Oral UT-15C (Treprostinil Diethanolamine) SR Tablets in Patients With Critical Limb Ischemia (CLI) and Ischaemic Rest Pain
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Treprostinil (Primary)
- Indications Chronic limb-threatening ischemia; Peripheral ischaemia
- Focus Adverse reactions; Therapeutic Use
- 26 Jun 2014 Status changed from unconfirmed to completed.
- 25 Jun 2014 New trial record